Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superior vena cava syndrome revisited

Y M Chen1, S Yang, R P Perng

  • 1Chest Department, Veterans General Hospital-Taipei, Taiwan, ROC.

Japanese Journal of Clinical Oncology
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-photon avalanche diodes in 0.18-μm high-voltage CMOS technology.

Optics express·2017
Same author

Platelet factor 4 upregulates matrix metalloproteinase-1 production in gingival fibroblasts.

Journal of periodontal research·2017
Same author

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study).

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.

Alimentary pharmacology & therapeutics·2015
Same author

Age-related changes in dynamic compressive properties of trochanteric soft tissues over the hip.

Journal of biomechanics·2015
Same author

Survivin SNP-carcinogen interactions in oral cancer.

Journal of dental research·2012
Same journal

Age-standardized mortality-to-incidence ratio for lymphoma in the world.

Japanese journal of clinical oncology·2026
Same journal

Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.

Japanese journal of clinical oncology·2026
Same journal

Progress in siRNA nucleic acid therapeutics and challenges in their application to cancer treatment.

Japanese journal of clinical oncology·2026
Same journal

Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer.

Japanese journal of clinical oncology·2026
Same journal

Impact of pre-existing schizophrenia spectrum disorder on the receipt of invasive and systemic therapy for gastric cancer: a multicenter nationwide cohort study in Japan.

Japanese journal of clinical oncology·2026
Same journal

De-escalation of breast surgery for early stage breast cancer.

Japanese journal of clinical oncology·2026
See all related articles

Superior vena cava syndrome (SVCS) in Chinese patients is often malignant. Early SVCS manifestation indicates a poor prognosis, but survival varies by cancer type, with lymphoma/leukemia patients faring best.

Area of Science:

  • Oncology
  • Clinical Medicine

Background:

  • Superior vena cava syndrome (SVCS) is a critical condition often linked to malignancy.
  • Understanding prognostic factors is crucial for managing SVCS patients effectively.

Purpose of the Study:

  • To analyze prognostic factors in patients with SVCS.
  • To evaluate the impact of initial management on outcomes for SVCS patients.

Main Methods:

  • A clinical review of 137 patients with SVCS treated between 1989 and 1993.
  • Analysis of prognostic significance of SVCS development in lung cancer subtypes.
  • Comparison of survival rates based on the timing of SVCS manifestation and underlying malignancy.

Main Results:

  • Malignant diseases were the primary cause of SVCS in the studied Chinese population.

Related Experiment Videos

  • SVCS development was a significant negative prognostic factor in non-small cell lung cancer (NSCLC) but not small cell lung cancer (SCLC).
  • Patients presenting with SVCS as the initial sign of malignancy had poorer prognoses than those diagnosed later. Survival rates varied significantly by cancer type: lymphoma/leukemia (best), malignant thymoma, SCLC, NSCLC, and metastatic cancer (worst). Rapid symptom onset correlated with shorter survival in lung cancer, particularly SCLC.

    • Conclusions:

    • The timing of SVCS presentation and the specific underlying malignancy are critical prognostic indicators.
    • While rapid onset impacts survival, initial radiotherapy or chemotherapy did not affect overall survival in SCLC patients with SVCS.